Application no. and date | 19160722.5 (espacenet) (Federated) (European Patent Register), 20121219 | Patent/reg. no. and date | DK/EP 3539982, 20250219 | Publication date | 20190918 | Priority no. and date | US 201161580169 P, 20111223 | EP pub. no. and date |
EP 3539982 20190918 | Effective date | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | Applicant ref. no. | | Inventor | TCHISTIAKOVA, Lioudmila, 19 Abbot Bridge Drive
Andover, MA 01810, US, CALABRO, Valerie, Résidence "Le Baoutailla", Apt. 34 Avenue de Carro 13500
13500 Carro, FR, MARQUETTE, Kimberly, 66 Springfield Street Apt. 1
Somerville, MA 02143, US, BENNETT, Eric, 45 Morningside Drive
Arlington, MA 02474, US, TUMEY, L. Nathan, 37 William Street
Pawcatuck, CT 06379, US, BIKKER, Jack, 22 Woodland Street
Little Silver, NJ 07739, US, GRAZIANI, Edmund, 497 South Pascack Road
Chestnut Ridge, NY 10977, US | Representative | | Opponent | | IPC Class | C07K 16/00 (2006.01) , C07K 16/30 (2006.01) | Title | ENGINEERED ANTIBODY CONSTANT REGIONS FOR SITE-SPECIFIC CONJUGATION AND METHODS AND USES THEREFOR | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|